Marrone Bio Innovations, Inc. (MBI) has been added to the Russell Microcap Index after the market closed on June 23, 2017.

"We are very pleased to have joined the Russell Microcap Index," said Dr. Pamela Marrone, Founder and CEO of Marrone Bio Innovations. "This is an important milestone for Marrone Bio Innovations and represents an opportunity to increase our visibility within the public market investment community."
Marrone Bio Innovations is an industry leader in the rapidly growing biopesticide market, as its ability to discover and rapidly commercialize novel products is unmatched within the industry.
The Russell Microcap Index is a capitalization weighted index which measures the performance of up to 2,000 leading microcap company stocks in the United States. FTSE Russell, a leading global index provider, determines membership for its equity indices primarily by objective, market-capitalization rankings and style attributes.
Indexes provided by FTSE Russell are widely used by investment professionals for index funds and as benchmarks for investment strategies. Approximately $8.4 trillion in assets are benchmarked to Russell Indexes.